Dhampur Bio Organics Surges 29.31%: 4 Key Factors Behind the Rally

Jan 24 2026 11:00 AM IST
share
Share Via
Dhampur Bio Organics Ltd delivered a remarkable weekly performance, surging 29.31% from ₹74.45 to ₹96.27 between 19 and 23 January 2026, significantly outperforming the Sensex which declined 3.31% over the same period. The week was marked by a strong quarterly turnaround announcement, a dramatic upper circuit rally, and mixed technical signals, reflecting a complex but optimistic market response amid sector challenges.




Key Events This Week


Jan 19: Stock opens strong at ₹77.14 (+3.61%) despite Sensex decline


Jan 21: Sharp rebound with 7.04% gain to ₹80.30 amid sector weakness


Jan 22: Quarterly results reveal strong turnaround; stock steady at ₹80.23


Jan 23: Surges 19.99% to ₹96.27, hitting upper circuit on robust buying





Week Open
Rs.74.45

Week Close
Rs.96.27
+29.31%

Week High
Rs.96.27

Sensex Change
-3.31%



19 January 2026: Strong Opening Amid Market Weakness


Dhampur Bio Organics Ltd began the week on a positive note, closing at ₹77.14, up 3.61% from the previous close of ₹74.45. This gain contrasted with the Sensex’s 0.49% decline to 36,650.97, signalling early investor interest in the stock despite broader market weakness. The volume of 6,491 shares indicated moderate trading activity, setting a constructive tone for the week ahead.



20 January 2026: Profit Taking and Market Pressure


The stock retreated to ₹75.02, a 2.75% decline, on relatively lower volume of 2,810 shares. This pullback coincided with a sharper Sensex fall of 1.82% to 35,984.65, reflecting broader market pressures. The dip appeared to be a short-term correction following the prior day’s gains, with investors possibly awaiting fresh catalysts.



21 January 2026: Sharp Rebound Defies Sector Downtrend


Dhampur Bio rebounded strongly, surging 7.04% to ₹80.30 on heavy volume of 12,419 shares. This rally was notable as the Sensex declined 0.47% to 35,815.26, underscoring the stock’s resilience amid sector and market weakness. The sharp gain suggested renewed buying interest, possibly in anticipation of upcoming quarterly results or other positive developments.



22 January 2026: Quarterly Turnaround Announcement and Steady Price


The company reported a strong quarterly turnaround for the December 2025 quarter, with profit before tax excluding other income soaring 423.0% to ₹16.73 crores and profit after tax surging 3853.2% to ₹16.90 crores compared to the previous four-quarter average. Operational efficiency improved markedly, with debtor turnover ratio reaching 53.67 times, the highest in recent history.


Despite these encouraging fundamentals, non-operating income contributed 34.85% of profit before tax, signalling some caution. The stock price remained steady at ₹80.23, down marginally by 0.09%, while the Sensex gained 0.76% to 36,088.66. The muted price reaction suggested investors were digesting the results cautiously, weighing the strong operational turnaround against sector headwinds and non-core income reliance.




Handpicked from 50, scrutinized by experts – Our recent selection, this Mid Cap from Bank - Public, is already delivering results. Don't miss next month's pick!



  • - Expert-scrutinized selection

  • - Already delivering results

  • - Monthly focused approach


Get Next Month's Pick →




23 January 2026: Explosive Upper Circuit Rally on Heavy Volume


Dhampur Bio Organics Ltd surged 19.99% to close at ₹96.27, hitting the upper circuit limit amid robust buying pressure. The stock opened with a 2.76% gap-up and traded in a wide range between ₹82.00 and ₹95.76. The total traded volume was approximately 11.64 lakh shares, with a turnover of ₹10.72 crore, reflecting intense market enthusiasm.


This rally significantly outpaced the sugar sector’s 1.22% decline and the Sensex’s 0.28% fall, highlighting company-specific momentum. The upper circuit freeze indicated substantial unfilled demand, signalling strong bullish sentiment. However, delivery volumes had declined by 30.21% compared to the five-day average, suggesting some speculative or short-term trading activity.


Technically, the stock traded above all key moving averages, reinforcing a strong upward trend. Despite this, mixed technical signals from momentum oscillators and a modest market cap grade of 4 counsel caution for longer-term investors.




Is Dhampur Bio Organics Ltd your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!



  • - Better alternatives suggested

  • - Cross-sector comparison

  • - Portfolio optimization tool


Find Better Alternatives →




Daily Price Comparison: Dhampur Bio Organics Ltd vs Sensex


















































Date Stock Price Day Change Sensex Day Change
2026-01-19 Rs.77.14 +3.61% 36,650.97 -0.49%
2026-01-20 Rs.75.02 -2.75% 35,984.65 -1.82%
2026-01-21 Rs.80.30 +7.04% 35,815.26 -0.47%
2026-01-22 Rs.80.23 -0.09% 36,088.66 +0.76%
2026-01-23 Rs.96.27 +19.99% 35,609.90 -1.33%



Key Takeaways


Positive Signals: The company’s quarterly results revealed a strong operational turnaround with profit before tax excluding other income rising 423.0% and profit after tax surging 3853.2% compared to the previous four-quarter average. Improved debtor turnover ratio to 53.67 times indicates enhanced working capital efficiency. The stock’s 29.31% weekly gain and upper circuit hit demonstrate strong market enthusiasm and technical momentum.


Cautionary Notes: A significant 34.85% of quarterly profit before tax was derived from non-operating income, which may introduce earnings volatility. Delivery volumes declined despite price gains, suggesting some speculative trading. The Mojo Grade remains at Sell, reflecting ongoing risks. Mixed technical indicators and a modest market cap grade of 4 highlight the need for cautious monitoring amid sector cyclicality and regulatory uncertainties.



Conclusion


Dhampur Bio Organics Ltd’s week was characterised by a striking price rally driven by a strong quarterly turnaround and robust buying interest culminating in an upper circuit hit. The stock outperformed the Sensex by a wide margin, signalling renewed investor focus despite the sugar sector’s challenges. However, mixed technical signals and reliance on non-operating income warrant a balanced view. While short-term momentum is positive, the company’s longer-term performance and sector headwinds suggest that investors should remain vigilant and monitor upcoming developments closely.






{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News